Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report

• Angela L. Liang,
• Payam Katebi Kashi,
• Mark Hopkins,
• Anna Beavis,
• Stephanie Gaillard,
• Ie-Ming Shih,
• Amanda N. Fader

Affiliations

Angela L. Liang

The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD 21287, United States

Payam Katebi Kashi

The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD 21287, United States

Mark Hopkins

Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21287, United States

Anna Beavis

The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD 21287, United States

Stephanie Gaillard

The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD 21287, United States; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD 21287, United States

Ie-Ming Shih

Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21287, United States

Amanda N. Fader

The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD 21287, United States; Corresponding author at: 600 N Wolfe St, Phipps Bldg, Rm 287, Baltimore, MD 21287, United States.